-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Capture the Cannabis Market Momentum with Canopy Growth Stock
We could be witnessing the start of a powerful comeback in CGC stock. Add Canopy Growth to your portfolio to ride high on the cannabis wave.
Should You Believe the Long-Term Narrative for Tilray Stock?
Once a high-flying cannabis player, Tilray stock has floundered along with the rest of the industry. But having recently found a bottom, speculators may be tempted to bet on TLRY’s long shot but viable narratives.
Now Is Not the Time to Buy Cronos Stock
CRON stock looks unlikely to make any upward movement in the near term, making it a poor choice in the marijuana space right now.
Leadership Transition Issues Exacerbate to CGC Stock Woes
Canopy Growth continues to have issues with its leadership transition. Because of this the price of CGC stock has declined.
Buckle Up and Get Yourself Some Shares of Aurora Cannabis Stock
There's nothing like the smell of cheap cannabis stocks -- and it doesn't get much cheaper than Aurora Cannabis stock right now.
Avoid Aurora Cannabis Stock Until Investor Fears Subside
Aurora Cannabis stock is in a downtrend that it cannot shake off. Strong fourth-quarter revenue numbers failed to impress. What's next?
Canopy Growth Stock Faces Big Problems
Canopy Growth stock faces big problems. The company needs to reach $1 billion CAD in sales to break even, but is nowhere near that level.
Canopy Growth Stock Emerges as Top Pick
CGC stock still isn't a name fit for grandma's safety portfolio, but Canopy Growth may be moving back into a bullish mode.
The ‘Secret’ Ingredient Set to Send Marijuana Stocks Soaring
Marijuana companies are right now hitting the investing sweet spot. Here's why now is the time to buy.
InvestorPlace Roundup: Aphria Stock Needs Better Friends
While oil stocks garnered the bulk of attention from many investors, readers were also interested in marijuana stocks and Nio.
Hexo Stock Could Fall After Its Earnings Release
Hexo stock could fall after its fiscal Q4 earnings release. Investors should expect an accelerated burn rate now that Hexo owns Newstrike.
3 Biotech Stocks That Show The Good, The Bad and the Ugly Side of This Sector
When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).
Here’s Why Aurora Cannabis Stock Stumbled
Nowadays, cannabis-related companies need credibility of the financial variety. This focus on the fundamentals has struck its latest victim, Aurora Cannabis stock.
Aurora Cannabis (ACB) Stock: The Real Story With This Earnings Report
Aurora Cannabis (ACB) dropped roughly 9.5% today on last night’s quarterly results. But there’s a lot more to this story behind the headlines – and a major upside catalyst on the horizon. So let’s take a look.
Expect Cronos Stock to Fall as Losses Widen
Cronos management announced that EBITDA losses will likely widen in the second half of the year. Investors will see CRON stock fall further.
Weak Earnings Might Cause Aurora Cannabis Stock to Keep Falling
An earnings disappointment calls into question the valuation of Aurora Cannabis stock. Investors should continue to avoid ACB stock.
Canopy Growth Stock Needs to Be One of Your Main Cannabis Plays
Bank of America's Canadian cannabis market share study reveals Canopy Growth is an early market leader. The numbers suggest Canopy Growth stock is well-positioned to deliver long-term gains for investors.
As Canadians Get Ready for Edibles, is Hexo Stock Ready to Bounce?
Hexo stock is well-poised to benefit from the next stage of cannabis legalization north of border. Gummies and drinks could fuel HEXO gains.